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ABSTRACT The outer mitochondrial membrane (OMM) is the last barrier between the mitochondrion and the cytoplasm.
Breaches of OMM integrity result in the release of cytochrome c oxidase, triggering apoptosis. In this study, we used calibrated
gold nanoparticles to probe the OMM in rat permeabilized ventricular cells and in isolated cardiac mitochondria under quasi-
physiological ionic conditions and during permeability transition. Our experiments showed that under control conditions, the OMM
is not permeable to 6-nm particles. However, 3-nm particles could enter the mitochondrial intermembrane space in mitochondria
of permeabilized cells and isolated cardiac mitochondria. Known inhibitors of the voltage-dependent anion channel (VDAC),
Ko¨nig polyanion, and 4,49-diisothiocyanatostilbene-2,29-disulfonic acid inhibited this entrance. Thus, 3-nm particles must have
entered themitochondrial intermembrane space through the VDAC. The permeation of the isolated cardiacmitochondria OMM for
3-nm particles was;20 times that in permeabilized cells, suggesting low availability of VDAC pores within the cell. Experiments
with expressed green ﬂuorescent protein showed the existence of intracellular barriers restricting the VDAC pore availability in
vivo. Thus, our data showed that 1), the physical diameter of VDAC pores in cardiac mitochondria is $3nm but #6 nm, and
2), permeability transition-related mitochondrial swelling results in breaching and disruption of the OMM.
INTRODUCTION
Mitochondria are important intracellular organelles, that
when triggered, orchestrate cell death through a cascade of
events launched by apoptogenic proteins. An increase in mito-
chondrial membrane permeability to macromolecules is one
of the key events in apoptotic and necrotic death, although
the detailed mechanisms remain controversial (1,2).
Recently we described intracellular sarcoplasmic aquatic
diffusion pathways (SPADPs) in ventricular cardiomyocytes
(3). This work explored how gold nanoparticles could move
within a cell and its organelles. Particularly, we showed a
difference in the distribution of 3- and 6-nm particles within
ventricular cells. The 3-nm particles were localized along the
Z-lines and the intermyoﬁbrillar mitochondria and were also
seen inside the mitochondria and nucleus, whereas the 6-nm
particles were primarily found along the Z-lines but not in the
mitochondria or nucleus. Here we continue to study SPADPs
in ventricular cells. In our previous study (3) we suggested
that 3-nm particles could penetrate the outer mitochondrial
membrane (OMM) through the voltage-dependent anion
channel (VDAC).
Theoretically, membrane impermeant probes could enter
mitochondria through VDACs (4,1), through permeability
transition (PT) pores (5–7,2), through mitochondrial apoptosis-
related channels (MACs)(8,9), through apoptosis-related
ceramide pores (10,11), through protein import channels
(translocase outer membrane, TOM), and/or through possi-
ble preparative damage to the OMM (12–14,2). Only VDAC
and TOM40 are relevant to normal mitochondrial function-
ing. The four other mechanisms noted above are related to
apoptosis and/or PT-related mitochondrial swelling (9,15).
TOM40 is a cation-selective high-conductance channel
(16). The effective internal diameter for TOM was probed
with preproteins conjugated to gold clusters and determined
to be between 2.0 and 2.6 nm (17). These channel charac-
teristics, if correct, exclude the possibility of TOM40 being
an entry pathway for nanoparticles $3 nm in size. Thus,
under quasi-physiological ionic conditions, only VDAC could
allow our probes to enter isolated cardiac mitochondria (ICM).
A low-selective VDAC is the only known ionic channel
that permits the fast exchange of molecules and ions between
extramitochondrial and mitochondrial intermembrane spaces
(MIMS) (18–21,7,1,22). Except for a relatively few mem-
brane-permeant lipophilic compounds (e.g., molecular oxy-
gen, acetaldehyde, short chain fatty acids), all metabolites
that enter and leave the mitochondria must cross the OMM
through the VDAC (22). The protein structure of VDAC
have been described in detail for nonmuscle (23,4,20,24) and
cardiac cells (25). VDAC is a highly conserved 30–32 kDa
protein (26). Each VDAC protein forms a barrel in the bilayer
comprised of a transmembrane a-helix and 13 transmembrane
b-strands. This b-barrel encloses an aqueous channel of 2–
3.2 nm in internal diameter, which in the open state allows
passage of nonelectrolytes up to ;5 kDa (27,20,1,28,22).
The size of the VDAC pore is directly connected to the
problem of cytochrome c release from MIMS. The release of
free cytochrome c oxidase under some conditions induces
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programmed cell death—apoptosis (29,13,30,14,2). There is
also some evidence that VDAC could be involved in the PT
pore formation (5–7,2, but see Krauskopf et al. (31)). Mean-
while, both VDAC and PT were shown to be connected to
the release of cytochrome c initiating apoptosis (13,29,30,32).
It has been suggested that cytochrome c could be released
from the MIMS via several mechanisms: 1), as result of PT-
related swelling, which induces OMM rupture (33,13); 2),
through a special channel formed by four VDACs (32); 3),
through the MACs (8,9), and/or 4), through ceramide pores
(10,11). The ceramides form oligomeric barrel-stave channels
with estimated diameters $10 nm, but only under apoptotic
conditions (12,13). To induce the release of macromolecules
from the MIMS under normal conditions, ceramides should
be added directly to isolated mitochondria (34). The channel
activity of MAC correlates with the presence of proapoptotic
Bax in the OMM (8). Under normal conditions, Bax predom-
inantly exists as a monomer in the cytosol (35). Dimerization
of Bax results in its translocation to the OMM, mitochon-
drial dysfunction, and apoptosis (35,1). Our experimental
conditions excluded translocation of Bax to the OMM and
provided us with data in support of PT-related swelling-
induced OMM rupture.
Our previous article (3) focused on SPADPs and we only
noted that 3- but not 6-nm particles were found in the mi-
tochondria of permeabilized cells. Here we investigate the
distribution of these nanoparticles within the mitochondrial
borders and in close proximity to the OMM from the cyto-
solic side and expand the nanoparticle approach to investigate
mitochondrial membrane for ‘‘transparency’’ to nano-objects.
In this article, we present data on the physical clearance of
the cardiac VDAC pore under quasi-physiological ionic con-
ditions and suggest a new approach to the study of VDAC
pharmacology in vitro.
METHODS
Isolation of heart mitochondria
Hearts from male 300–350 g Sprague-Dawley rats were rapidly removed,
chopped, and homogenized in ice-cold isolation buffer containing 225 mM
mannitol, 75 mM sucrose, 5 mM Hepes, 1 mM EGTA, and 1 mg/ml bovine
serum albumin (BSA) (fatty acid free) with the pH adjusted to 7.4 using
KOH. After the ﬁrst centrifugation (3 min, 600 3 g), the supernatant was
collected and then centrifuged at 10,000 3 g for 10 min. The supernatant
and the light fraction of the pellet were discarded. The pellet was resus-
pended in isolation buffer and centrifuged at 10,000 3 g for 10 min. The
pellet (mitochondria) was resuspended in 100 ml of isolation buffer without
EGTA. The ﬁnal suspension of the mitochondria (50–60 mg/ml protein
assayed by Biuret) was stored on ice and used in experiments within 4 h of
preparation.
Isolated cardiac mitochondria (ICM) were placed (5 ml) on a dry cov-
erslip as described previously (36). After 30 s, the unattached mitochondria
were washed out with an experimental solution containing 100 mM K1
aspartate, 20 mM KCl, 3 mM MgATP, 0.81 mM MgCl2 (free [Mg
21] ¼
;1 mM), 0.1 mM EGTA, 0.03 CaCl2 ([Ca
21]free ¼ ;90 nM), 20 mM
Hepes, 10 mM phosphocreatine (disodium salt), 5 U/ml creatine phospho-
kinase, 3 mM glutamic acid, and 3 mM malic acid, pH 7.2. This is a slightly
modiﬁed standard solution used to mimic the cardiac cytoplasm content for
experiments in permeabilized ventricular cells (37). The free [Ca21]free and
[Mg21]free at the given total Ca
21, Mg21, ATP, and EGTA concentrations
were calculated using WinMAXC32 2.5 (Stanford University, Stanford,
CA). Measurements with a D-Scan spectroﬂuorometer (PTI, Monmouth
Junction, NJ) and the Ca21 indicator fura-2 (TefLabs, Austin, TX) showed
that real [Ca21]free in the experimental solution was ;100 nM.
Unless speciﬁed otherwise, all chemicals were from Sigma (St. Louis,
MO).
Cell isolation
Single ventricular myocytes were obtained from adult male Sprague-Dawley
rat hearts by enzymatic dissociation as described previously (38). Before
permeabilization, the cells were kept in the standard Tyrode solution con-
taining (in mM) 140 NaCl, 5.4 KCl, 0.5 MgCl2, 1 CaCl2, 10 Hepes, 0.25
NaH2PO4, 5.6 glucose, pH 7.3. Single ventricular myocytes were perme-
abilized with 0.007% saponin (60 s) as described previously (37). After
permeabilization, the cells were exposed to the solution containing 100 mM
K1 aspartate, 20 mM KCl, 3 mM MgATP, 0.81 mM MgCl2 ([Mg
21]free ¼
;1 mM), 0.5 mM EGTA, 0.114 mM CaCl2 ([Ca
21]free¼;90 nM), 20 mM
Hepes, 10 mM phosphocreatine (disodium salt), 5 U/ml creatine phospho-
kinase, 3 mM glutamic acid, 3 mMmalic acid, and 1% polyvinylpyrrolidone
(PVP), pH 7.2.
Electron microscopy
The isolated saponin-permeabilized ventricular cells were prepared for
electron microscopy (EM) as described previously (3). The preparation
included ﬁxation of the cells in 6% glutaraldehyde and embedding in LR
White resin (Ted Pella Inc., Redding, CA). For preparation of a monolayer
of ICM for the EM, we slightly modiﬁed the procedure. Brieﬂy, still attached
to coverslips, ICM were ﬁxed in 1% glutaraldehyde and 4% paraformal-
dehyde in 0.1 M Na-cacodylate buffer (pH 7.4) overnight at 4C, then rinsed
two times with the same buffer supplemented with 0.2 M sucrose and
postﬁxed with 1% osmium in s-Colloidine buffer (Electron Microscopic
Science, Hatﬁeld, PA). Then samples were en bloc stained (2% uranyl ace-
tate in 50% ethanol) for 1 h. After dehydration in an alcohol series, the
samples were embedded in LR White resin. Ultrathin sections were ob-
tained with an LKB III microtome, (LKB, Bromma, Sweden), collected on
Formvar-coated nickel grids, and stained for 15 min with 2% aqueous uranyl
acetate followed by lead citrate for 2 min at room temperature. Sections were
examined at 60 kV with a Zeiss electron microscope EM 10C/EM 10 CR
(Zeiss, Gottingen, Germany). Images were stored in tiff format.
Sometimes mitochondrial granules that are seen with Epon embedding
(39,40) were also present on LR White micrographs (3). However, these
granules are very rare and much less electron-dense than silver grains.
Therefore, they are easily recognized by digitally reducing the contrast of
the micrograph.
To probe the physical clearance of the VDAC pore, we used gold
nanoparticles (Ted Pella) coated with PVP with minimal sizes of;3 or 6 nm
as was described (3). The original average size of ‘‘5-nm’’ gold nanoparticles
used in our experiments was 56 0.75 (mean6 SD; Ted Pella ), whereas for
‘‘2-nm’’ colloidal gold only, the range of 1–3 nm is known. Theoretically,
the PVP adds ;2 nm to size of the gold core (3) and this ﬁnal size is im-
portant for our experiments. To measure the size of the PVP-coated ‘‘2-nm’’
nanoparticles, we employed Dynamic Light Scattering (Protein Solutions,
Wyatt Technology, Santa Barbara, CA). The average size of 2-nm gold
particles coated with PVP in our experimental solutions was 3.9 6 0.51
(mean 6 SD; n ¼ 10). However, theoretically the smallest particles in the
group must penetrate deeper into the cell or mitochondrion and will be
found in larger numbers than particles with the average size. Taking into
account the divergence in size (41) and shape (the PVP-coated particles are
not perfectly spherical; see Parfenov et al. (3)) within a group, the smallest
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PVP-coated particles in a group should be ;1 nm smaller in diameter
than the average size. Thus, in our experiments we used two groups of
particles with minimal sizes of;3 or 6 nm. Note also that gold particles with
a diameter of ,1 nm are unstable and not available as an unconjugated
colloidal gold. Thus, the smallest diameter of PVP-coated nanoparticles
could not be ,3 nm.
Calibrated gold nanoparticles pretreated with 1% PVP were added to
ICM or permeabilized ventricular cells after their attachment to coverslips.
The density of the nanoparticles in solution was 1.353 1014 per ml for 3-nm
particles, and 4.5 3 1013 per ml for 6-nm particles. We allowed 20 min for
the nanoparticles to diffuse into cells or 10 min to diffuse into ICM and then
the ICM or cells were ﬁxed for EM.
To prevent the subsequent movement of nanoparticles inside and outside
the mitochondria, we sealed all possible entryways to the mitochondria with
glutaraldehyde during ﬁxation (42,43). After preparation for EM, the gold
nanoparticles were visualized with silver using the BB International Silver
Enhancing Kit (Ted Pella). The size of the silver grains depends on the time
of exposure and the accessibility (i.e., depth of position within the section) of
the gold. We applied the solution for 8 min. Note because LR White is a
water-soluble resin, lipid structures are much ‘‘softer’’ after polymerization.
This explains the direction of growth of the silver grains around gold cores in
the deep of slice toward membranes. To reveal highly electron-dense silver
grains, we digitally reduced the image contrast by 70–80% (until only silver
particles were clearly seen) with Adobe Photoshop 7.0 (Adobe Systems, San
Jose, CA).
Data were expressed as particles/mm3, taking into account that particles
were visualized through the entire thickness of an ultrathin section and
assuming the average thickness of the section to be 80 nm. Mitochondrial
diameter was measured from round mitochondria or derived from elliptic
mitochondria as the square root of the product of maximal and minimal
elliptic diameters.
Immunoﬂuorescence
Freshly isolated ventricular cells were ﬁxed in 100% ethanol at -20C for 1/2 h.
They were then washed four times for 15 min with phosphate-buffered saline
(PBS), 5% normal goat serum (NGS), 3% BSA. Anti-VDAC (anti-Porin,
Ab-5, polyclonal, IgG, Calbiochem, Oncogene Research Product, San
Diego, CA) was added at a dilution of 1:50 and incubated overnight at 4C.
As a control, no primary antibody was added to the cells (only PBS, 5%
NGS, and 3% BSA). The next day, both control and experimental cells were
washed four times for 15 min with PBS, 5% NGS, 3% BSA, second anti-
body conjugated to Alexa 488 (Molecular Probes, Eugene, OR) was added
at a dilution of 1:200, and the cells incubated for 2 h on a rocking platform at
room temperature. The cells were then washed four times for 15 min. Slides
were made using Slow Fade Light (Molecular Probes) as a mounting me-
dium and stored at 20C until examined.
Cell transfection
For cell transfection, we used Adenovirus 5, which expresses enhanced green
ﬂuorescent protein (GFP; Clontech Laboratories, Mountain View, CA) driven
by the cytomegalovirus promoter (AdGFP), which was produced by the
Molecular Genetic Core Facility (University of Maryland, Baltimore, MD).
Freshly prepared adult rat cardiac myocytes were plated at 50% conﬂuence
on laminin-covered coverslips in 35 mm dishes. The plating medium
contained: M199 supplemented with 5 mM taurine, 4.4 mM creatine, 2 mM
L-carnitine, 3 mM (2-mercaptopropionyl)glycine (i.e., MPG), 19.4 mM
glucose, 0.01 U/ml insulin, 0.2% BSA, 50 U/ml penicillin G sodium salt,
and 50 mg/ml streptomycin sulfate; 2 h after plating, the bathing solution
was replaced with 1 ml of medium containing AdGFP at concentrations 0.6–
2.5 3 109 particles/ml. After 90 min, 2 ml of the fresh original medium per
dish was added to cells. The cells were used for confocal imaging 2 days
after transfection.
Confocal imaging
Prepared slides were examined with a Carl Zeiss Laser Scanning Confocal
System (LSM 510, equipped with a C-Apochromat 63 3/1.2 W corr ob-
jective) with excitation at 488 nm and a LP ﬁlter 505 nm. All measurements
were done from optical slices ,1 mm in thickness with a laser beam power
of ;0.08 mW.
X-Y scan images were acquired as a mean of 8 and stored in tiff format.
Mitochondrial diameters were measured from ;1 mm optical slices using
ImageJ 1.31v (National Institutes of Health, Bethesda, MD).
For deconvolution, high resolution z-stacks (stacks with a maximum
pixel size of 0.1 mm 3 0.1 mm 3 0.2 mm) were processed using Volocity
3.5.1 (Improvision, Lexington, MA). Images were deconvolved using the
iterative restoration algorithm developed by Improvision (Lexington, MA).
Experiments were performed at room temperature (21–23C). Data were
expressed as mean 6 SE. Comparisons were made by using the Student’s
t-test, and differences were considered signiﬁcant when P , 0.05.
RESULTS
Immunoﬂuorescence
In isolated cardiac mitochondria, VDAC (also known as
porin) was shown to be located in the OMM (44). Fig. 1
shows the distribution of VDAC within rat ventricular myo-
cytes. The immunoﬂuorescence is distributed around the mito-
chondria. The immunostaining reveals groups of perinuclear
and intermyoﬁbrillar (IMFMs) mitochondria, and is clearly
FIGURE 1 Distribution of VDAC in rat ventricular cell. Immunoﬂuores-
cent labeling. (A and B) Representative images of cells ﬁxed with ethanol.
The cells were incubated overnight with primary antibody. Two cells are
shown with lower (A) and higher (B) resolution. N, nucleus; PNM, peri-
nuclear mitochondria; and IMFM, intermyoﬁbrillar mitochondrion. Optical
slice is ;0.7 mm.
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absent from Z-lines. Fig. 1 B shows IMFM at higher
magniﬁcation when separate mitochondria can be seen. Simi-
lar distribution of VDAC was recorded for 30 other cells.
Permeabilized ventricular cells
Although LR White resin used in our experiments allowed
silver ions to penetrate through the thickness of the ultrathin
section, the ﬁnal size of the silver grain was smaller the
deeper the gold particle was in the section (see Fig. 2,
circles). Fig. 2 shows that despite high cytoplasmic density,
6-nm particles did not enter the mitochondria in permeabi-
lized cells. However, some particles were found in close prox-
imity to the OMM on the cytosolic side. Table 1 summarizes
all the data pertaining to the density of nanoparticles in our
experiments.
In contrast to the 6-nm particles, the 3-nm particles entered
mitochondria (Fig. 3, A and B; Table 1). Note that the aver-
age density of the 3-nm particles within mitochondria (;8
particles/mm3) is;2 times the density of the nanoparticles in
the cytosol and ;40 times the density within nucleus under
similar ionic conditions (3). In contrast, the density of 6-nm
particles was 7 times higher in cytosol (3) than within the
mitochondria of permeabilized cells. This indicates that
3-nm particles were trapped within the mitochondria.
If the nanoparticles were entering the mitochondria through
the VDAC, inhibition of VDAC should prevent their enter-
ing, because in the closed state VDAC is permeable only to
small cations (1). Pretreatment of the permeabilized cells
with VDAC inhibitors, 15–50 mg/ml Ko¨nig’s polyanion
(KPA; gift from Dr. Marco Colombini) or 100–300 mM 4,49-
diisothiocyanatostilbene-2,29-disulfonate (DIDS) (41,42,13,
28), reduced the number of 3-nm particles found in the
mitochondria by 80–90% (Fig. 3 B; Table 1). This suggests
that 3-nm particles entered the MIMS of permeabilized cells
through the VDAC.
Isolated cardiac mitochondria, 3-nm particles
The attachment of the ICM to coverslips permitted free gold
nanoparticles to wash away from the extramitochondrial
space during ﬁxation for EM. Fig. 4 A shows the location of
3-nm particles within mitochondria. Note that nanoparticles
within the ICM do not show a shape that is speciﬁc for PVP-
coated granules (3) and tend to aggregate. This suggests that
they, at least partially, lost their coating as they entered the
ICM. Indeed, neutral PVP should have only a weak tendency
to coat gold nanoparticles. Positively charged proteins (such
as cytochrome c oxidase) within mitochondria should at least
partially compete with the effect of gold positive charges.
This can result in partial or full ‘‘uncoating’’ of the nano-
particles.
Our EM ﬁxation and embedding procedures permitted
gold nanoparticles to be marked with silver through the entire
volume of the section and reduced the number of ‘‘mito-
chondrial granules’’ (see Parfenov et al. (3)). However, the
quality of the imaging would not be as good as would be
expected for Epon embedding (45). Therefore, to conﬁrm
the location of nanoparticles in the MIMS but not in the
mitochondrial matrix, we used a PT inhibitor, cyclosporin
(CsA). Fig. 4 B shows that pretreatment of the ICMwith CsA
did not prevent the entry of 3-nm particles (Table 1). Similar
to permeabilized ventricular cells, VDAC inhibitors, KPA
(15–50 mg/ml), and DIDS (100–300 mM) did signiﬁcantly
inhibited the entering of 3-nm particles by ;80% (Fig. 5, A
and B, correspondingly; Table 1), suggesting that under
FIGURE 2 Representative electron micrographs made using conventional
ﬁxation and silver enhancement show that despite high cytoplasmic density
6-nm particles do not enter mitochondria in permeabilized ventricular myo-
cytes. M, mitochondrion; Z, Z-line. The solid circles show nanoparticles
located deeper inside the ultrathin section and thus have a smaller diameter
after silver enhancement.
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control conditions 3-nm particles entered the MIMS through
the VDAC.
To increase VDAC gating and consequently restrict the
entrance of nanoparticles into ICM ((46), but see Rostovtseva
et al. (1)), we supplemented the bathing solution with 150
mM Ca21. As shown in Fig. 5 C, high [Ca21] resulted in the
predictable swelling and changes in mitochondrial ultra-
structure (6,12–14,2). Corresponding mean diameters for all
experiments with ICM are presented in Table 2. An increase
in [Ca21] in the bathing solution to 150 mM resulted in an
;100% increase in mitochondrial diameter. Although we
did not ﬁnd 3-nm particles within the ICM, they might have
been washed out through the membrane openings.
The graph presented in Fig. 5 D summarizes the data on
densities of 3-nm particles within the ICM. These data as-
sume that the mitochondrial nanogold particles entered ICM
through the VDAC, which in this case, must have a pore
diameter of $3 nm.
Interestingly, if, as it was shown earlier for permeabilized
ventricular cells (3), EM ﬁxation and embedding resulted in
an ;45% reduction in mitochondrial volume, then under
normal conditions the density of 3-nm particles in ICM was
;270 particles/mm3 before ﬁxation for EM. This is about
twice the original density of 3-nm particles in the experi-
mental solution (;120 particles/mm3). This suggests that
3-nm particles were indeed stuck in the MIMS, which takes
up only part of the mitochondrial space. As discussed above,
the neutral PVP could be partially stripped from the particles
in the middle of ICM due to the competing effects of
positively charged proteins. This would result in the particles
binding to proteins or in aggregation (3).
Another intriguing observation is that the density of 3-nm
particles in ICM under control conditions and after pretreat-
ment with KPA and DIDS was ;20 times higher then in
permeabilized ventricular cells (Table 1). This suggests that
diffusion of 3 nm particles in permeabilized cells was
signiﬁcantly restricted in comparison to the aqueous solution
in our ICM experiments. However, our GFP experiments
(see below) showed that diffusion of these size molecules is
very fast in permeabilized cells.
Isolated cardiac mitochondria, 6-nm particles
When 6 nm particles were added to ICM under control con-
ditions, they were not found inside the mitochondria (Fig. 6).
The density of 6-nm particles within ICM was 50 times less
than the density of 3-nm ones (Table 1). Also, unlike the
3-nm particles, 6-nm particles were found primarily in close
proximity to the OMM (Table 1; Fig. 6 B). If this attachment
is similar to the attachment of particles$6 nm to glycocalyx
as shown in our previous study (3), this would suggest the
existence of long chains of glycoproteins on the OMM sur-
face. Such structures can result from damage to the mito-
chondrial contacts (connecting pillars) to the surrounding
intracellular structures (3), mitochondria, and sarcoplasmic
reticulum (SR) during their isolation from cardiomyocytes.
Indeed, the number of 6-nm particles found on the OMM of
ICM was 70 times higher than in permeabilized ventricular
myocytes, whereas the density of the nanoparticles within
the mitochondria was only 4 times higher in ICM (Table 1).
This would suggest that the attachment of 6-nm particles to
the OMM might have resulted from the isolation of mito-
chondria from their natural environment.
Although the diameters of OMM pores may be sufﬁcient
to exclude 6-nm particles from entering the MIMS under
control conditions, there are two other possible reasons why
they did not pass to the geometrical center of the mitochon-
drion: a), MIMS properties (small distance between cristae
TABLE 1 Density of nanoparticles within mitochondria (particles/mm3) and in close proximity to the OMM (particles/mm)
Group: Ventricular cells: ICM:
Size: 3-nm: 6-nm: 3-nm: 6-nm:
Position: Within OMM Within OMM Within OMM Within OMM
Control 7.6 6 0.8 ;0.02 0.7 6 0.2z ;0.08z 150 6 14y ;0.04 3.1 6 1.4yz 5.6 6 0.4yz
n 742 417 114 160
KPA 0.8 6 0.5* ;0.01 – – 26.7 6 5.7*y ;0.02 – –
n 104 98
DIDS 1.4 6 0.9* ;0.01 – – 29.7 6 6.4*y ;0.00 – –
n 79 88
High [Ca21] – – – – 3.6 6 1.5* ;0.01 5.0 6 2.0 4.3 6 0.3z
n 104 65
CATR – – – – – – 26.8 6 5.0* 1.7 6 0.1*
n 103
Alamethicin – – – – – – 14.7 6 2.6* 0.5 6 0.1*
n 164
Mean 6 SE. Concentrations used: KPA, 50 mg/ml; DIDS, 300 mM; Ca21, 150 mM; CATR, 5 mM; alamethicin, 80 mg/ml.
*Data that are statistically different from the corresponding control.
yData that are statistically different from data for ventricular cells for the same size of nanoparticle.
zData that are statistically different from corresponding data for 3-nm particles within the same group (P , 0.01); n, number of measurements.
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and/or dense content), and/or b), the OMM pillar ‘‘debris’’
(left over from the mitochondrial isolation) blocked the
entrance. To determine what prevented 6-nm particles from
entering the mitochondria, we perforated the mitochondria
membranes with 5 mM carboxyatractyloside (CATR) or 80
mg/ml alamethicin. These agents can perforate both the outer
and inner mitochondrial membranes but in different ways.
CATR binds the C-state of the adenine nucleotide translocator
and stimulates the PT pore (6,47,48); whereas alamethicin
forms giant pores through both mitochondrial membranes
(49,50).
The 10 min pretreatment with CATR resulted in a
signiﬁcant increase in mitochondrial diameters (Table 2)
and facilitated the entrance of 6-nm particles into the mito-
chondria (Fig. 7 A). The density of particles within the ICM
after 5 mM CATR was ;10 times higher than that under
control conditions, whereas attachment of the particles was
reduced only 3 times (Table 1).
If 6-nm particles could pass through the PT pore, they
should enter the ICM matrix. However, aggregation of the
particles within the ICM (Fig. 7 A), which is similar to 3-nm
particles (Fig. 4), assumes that they entered only the MIMS.
Indeed, the simple perforation of both ICM membranes with
80 mg/ml alamethicin also resulted in mitochondrial swelling
and a signiﬁcant increase in the density of intramitochondrial
nanoparticles (Tables 1 and 2); however, there was no sign of
aggregation of 6-nm particles (Fig. 7 B).
Alamethicin forms giant protein pores in both mitochon-
drial membranes (49,50). Taking into account the original 3
times lower density of 6-nm particles in comparison to 3-nm
particles in the experimental solution and the ;4 times
alamethicin-induced increase in the volume of the mitochon-
drial slice (;2 times increase in diameter), the permeation of
ICM OMM for 6-nm particles after alamethicin was ;1.5
times higher than for 3 nm particles under control conditions.
A very similar increase in density of particles resulted from
the effect of CATR (;1.6 times increase). These experi-
ments showed that a), 6-nm particles did not enter the MIMS
and bind to the OMM only on the extramitochondrial side;
and b), neither the properties of MIMS nor the OMM pillar
‘‘debris’’, but the diameter of OMM pores, excludes 6-nm
particles from entering the MIMS under normal conditions.
Another way to perforate the OMM in cardiac mitochon-
dria is a Ca21-induced PT (6,13). Fig. 7 C shows the effect of
150 mM Ca21 on OMM permeability. The 6-nm particles
were found within ICM in much smaller amounts than after
CATR or alamethicin treatment (Table 1), despite a most
signiﬁcant increase in volume (Table 2). The graph presented
in Fig. 7 D summarizes the data. Visual analysis of ICM
ultrathin sections showed that the OMM is severely damaged
with high [Ca21] (see also Brustovetsky et al. (13)). This
suggests that 6-nm particles were washed out during EM
preparation.
If 6-nm particles enter the ICM after CATR treatment due
to multiple membrane breaches resulting from mitochondrial
swelling (51,13), this should be seen as a reduction in the
number of particles attached to the OMM (the breaches
increase the mitochondrial surface area without adding new
binding sites for the particles). Therefore, to evaluate the
extent of the damage to the OMM induced by the swelling,
FIGURE 3 Density of 3-nm particles within mitochondria in permeabilized
ventricular myocytes. (A) Representative electron micrographs made using
conventional ﬁxation and silver enhancement show that 3-nm particles enter
mitochondria in permeabilized ventricular cells.M, mitochondrion; Z, Z-line.
The solid circles show nanoparticles located deeper inside the ultrathin
section and thus have a smaller diameter after silver enhancement. (B) The
graph shows the load of mitochondria by the particles under marked
conditions. Asterisks indicate data that are statistically different from the
corresponding control (P , 0.01); n ¼ 79–742 (see Table 1).
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we calculated the number of attached 6-nm particles before
and after treatment with CATR or alamethicin. Fig. 8 and
Table 1 show that these numbers are signiﬁcantly reduced by
pretreatment with these compounds. Interestingly, high [Ca21]
did not change the number of attached particles suggesting
disruption of the OMM.
Distribution of green ﬂuorescent protein in
ventricular cell
To determine whether VDAC availability is restricted in intact
cells and to evaluate levels of diffusion of 3-nm particles in
permeabilized cells, we transfected ventricular cells with
GFP (n¼ 3). GFP is a 4.2 nm long cylinder with a cylindrical
diameter of only 2.4 nm (52). At pH 7.2, it has a negative
charge (–5.6; Protein Calculator v3.3, The Scripps Research
Institute, La Jolla, CA). The VDAC could be highly selective
to nucleotides (1); however, the shape, size, and negative
charge of GFP could allow it to pass through the VDAC of
cardiac mitochondria.
We expressed GFP in rat ventricular myocytes and imaged
them with confocal microscopy after 48 h. Fig. 9 shows that
GFP distributed primarily along the Z-lines and in the nu-
cleus, but not in perinuclear (Fig. 9 A, inset), subsarcolem-
mal, or intermyoﬁbrillar (Fig. 9 C) mitochondria. Although
ﬂuorescence was present in the IMFMs, three-dimensional
reconstruction from deconvoluted images showed that it
comes from out-of-focus areas and that all three types of
cardiac mitochondria are empty of GFP (data not shown).
Could GFP be bound to something located along the
Z-lines or does the pattern reﬂect free distribution of GFP?
Fig. 9 B shows the same region that was shown in the inset
for Fig. 9 A, but 1 min after permeabilization. Note that the
detection gain was signiﬁcantly increased to compensate for
a decrease in ﬂuorescence due to the leak of GFP from the
cell. Permeabilization of the cells with saponin resulted in the
release of GFP from all cell compartments excluding nucleus
within 1 min (n ¼ 20). Previously, we have shown a signiﬁ-
cant restriction of intracellular aqueous diffusion for particles
with size$6 nm in permeabilized cells (3). Thus, if GFP was
bound to another protein at the Z-line instead of being freely
distributed, that protein would have to be much smaller than
2 nm. However, there was the slight possibility of saponin
damage to the OMM, which could release GFP. Therefore,
to reveal any possible loading of the MIMS with GFP, we
reduced the time of exposure to saponin by half (30 s). Mem-
brane blebs ﬁlled with GFP conﬁrmed only slight perme-
abilization (Fig. 9 E).
After 30 min, ;50% of the cells showed at least traces of
GFP ﬂuorescence (Fig. 9 E). However, the GFP diffusion
from the nucleus was signiﬁcantly delayed (n ¼ 10). This
made the nucleus relatively brighter than the surrounding
cytoplasm. If the mitochondria were at least partially loaded
with GFP, they should also be seen as relatively brighter
structures after release of GFP from the cytoplasm. However,
the mitochondria lost their signal proportionally to the back-
ground.
All together, the presented GFP data suggest that a),
mitochondria of intact cells were not originally ﬁlled with
GFP (i.e., GFP cannot go through VDAC in its native envi-
ronment); b), GFP does not bind to sarcoplasmic proteins; c),
GFP could diffuse freely within the cell; and d), the space
along the Z-lines is opened to free diffusion of particles
;4 nm in size despite the glycogen localized in the same
area (40).
DISCUSSION
This is the ﬁrst investigation, to our knowledge, of perme-
ability of the cardiac OMM pores under quasi-physiological
ionic conditions and in their original environment. Under
normal conditions only VDAC would allow gold nano-
particles $3 nm in size to enter MIMS (see Introduction). In
our experiments, the entrance of 3-nm particles into MIMS
was signiﬁcantly restricted in solutions containing KPA and
DIDS (Fig. 5 D; Table 1), i.e., by two chemical compounds
FIGURE 4 Electron micrographs made using conventional ﬁxation and silver enhancement show the location of 3-nm particles in ICM. Representative
micrographs show ICM after 10 min of incubation with 3-nm particles in control solution (A), and in solution containing 2 mM CsA (B). M, mitochondrion.
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that were shown to be effective inhibitors of VDAC (53,
54,13,28). This suggests that they entered MIMS through the
VDAC pore.
Methodology
Theoretically, nanoparticles could enter ICM through VDAC,
or through holes in the OMM resulting from mechanical or
functional (PT-related) permeabilization of OMM. Under
our experimental conditions, the ICM look structurally and
functionally undamaged. For instance, Fig. 6 B shows ﬁne
mitochondrial ultrastructure. In our experimental solution,
we used physiological [Mg21] (;1 mM), which also inhibits
PT. This Mg21 effect, however, could be overcome with
high [Ca21] (55). To conﬁrm that our ICM were not initially
in the PT state, we performed experiments using CsA, which
has been shown to effectively block PT (6). CsA did not
change the average number of particles entering mitochon-
dria (Fig. 4 B, Table 1). In addition, we conﬁrmed mito-
chondrial and OMM structural and functional integrity by
preventing the ﬁlling of MIMS with membrane impermeant
ﬂuorescent probes with VDAC inhibitors DIDS and KPA
(56), and (2) by loading mitochondrial matrices with ﬂuo-
rescent probes, TMRM, and ﬂuo-3 (AM) (Molecular Probes)
in ICM and permeabilized cells (six experiments; not shown).
The load with TMRM is a standard test for mitochondrial
membrane potential, and the ﬂuo-3 (AM) could produce ﬂuo-
rescence only after deesteriﬁcation within the mitochondrial
matrix.
Our methods also allowed us to discriminate silver grains
from ‘‘mitochondrial granules’’; however, in our experi-
ments with 3-nm particles (Figs. 4 and 5), the silver grains
did not have a typical shape for PVP-coated sols as in the
experiments with 6-nm particles under control conditions
(Fig. 6 B). The 3-nm particles looked aggregated (3). Similar
aggregations could also be found within mitochondria when
6-nm particles entered the ICM after CATR (Fig. 7 A). This
suggests that the PVP coating on the particles was at least
partially removed (see Parfenov et al. (3)), possibly by com-
petition from positively charged proteins (as cytochrome c),
or by positive charges on the inner mitochondrial membrane,
which would compete with the positive charge of Au31 lo-
cated within the gold nanoparticles (57). If this is true, aggre-
gation of particles might be a sign of the matrix’s functional
and structural integrity. Indeed, when the inner mitochondrial
membrane was permeabilized, an even higher concentration
FIGURE 5 Known inhibitors of VDAC prevent entering of 3-nm particles
into MIMS. Representative electron micrographs made using conventional
ﬁxation and silver enhancement show ICM after 10 min of incubation with
3-nm particles in solutions containing 50 mg/ml KPA (A), 300 mM DIDS
(B), or 150 mMCa21 (C). Nanoparticles were added to the ICM 10 min after
the corresponding agent. (D) The graph shows the relative load of ICM by
the particles under marked conditions (n¼ 56–114). For concentrations used
see Table 1. Asterisks indicate data that are statistically different from the
corresponding control (P , 0.01).
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of nanoparticles fails to create such gold aggregations
(Fig. 7 B).
Another interesting phenomenon is the aggregation of
6-nm particles on the ICM OMM (Fig. 6; Table 1). This is
similar to what was found for nonpermeabilized cells, where
only particles $6 nm attached to the sarcolemma (3). We
suggested that this was due to defects in covering of big
nanoparticles with PVP, which allowed long branches of
glycoproteins to be bound by gold core (41). The OMM bound
sites for 6-nm particles could result from the disruption
during preparation of ICM of multiple connecting pillars
between mitochondria and the surrounding structures shown
for cardiac cells (3). Indeed, in permeabilized cells, the number
of 6-nm particles located in close proximity to the OMMwas
considerably less in comparison to ICM (Table 1).
Size of the VDAC pore
The VDAC was shown to be a convergence point for various
signaling pathways leading to the cell death, and all of them
are mediated with the release of cytochrome c oxidase from
MIMS (2). Under normal conditions, positively charged cy-
tochrome c (the smallest side of cytochrome c is ;3 nm; see
Margoliash (58)) stays in the MIMS (1). Thus, VDAC’s pore
opening cannot be much bigger then 3 nm. Our experiments
showed that uncharged particles$3 nm but not$6 nm could
enter MIMS. This is in good agreement with previous data
by Mannella’s group, which showed that the diameter of the
open VDAC pore to be ;3 nm (4). However, our measure-
ments are in disagreement with those made with polyethyl-
ene glycols by Carneiro et al. (27). They showed that the
VDAC’s pore is asymmetric, and in the open state had a
minimum diameter of ;2 nm. Despite a slight diversity in
size, the nanoparticles we designated ‘‘3-nm’’ could not
have particles with diameter #2 nm. Gold particles with
diameter of #1 nm are unstable and not available as a
unconjugated colloidal gold (Ted Pella). In addition, PVP
10000 adds ;2 nm to the diameter of gold particle (3)
assuming tight packing on the particle surface. However,
even if the original size of the gold particle was less than 1 nm
theoretically, it would lead to less compact packing of the
PVP and should add more than 2 nm to diameter of the
particles. Therefore, we could conclude that our particles
could not be less then 3 nm in size and that the VDAC pore
diameter is $3 nm. The disagreement with measurements
made with polyethylene glycols (27) could be explained by
changes in polyethylene glycol shape within the pore toward
increase in size.
Our data were supported indirectly by experiments with
PVP-coated nanoparticles and ferritin loaded into cells. In
1962, C. M. Feldherr showed that after cell injection, gold
nanoparticles ;5 nm in size did not enter the MIMS (59),
whereas ferritin was localized between the outer and inner
mitochondrial membranes (60). A similar distribution of
ferritin could be seen in liver cells (61) and skinned skeletal
ﬁbers (42). Thus, ferritin passed through the VDAC pore into
MIMS and its smallest size should be smaller then the pore.
The diameter of the ferritin molecule iron core is ;2.0 nm
TABLE 2 Diameter (mm) of ICM from ultrathin-section electron micrographs
Control CsA KPA DIDS High [Ca21] CATR Alamethicin
0.65 6 0.01 0.62 6 0.02 0.63 6 0.04 0.71 6 0.03 1.24 6 0.03* 0.91 6 0.03*y 1.07 6 0.03*yz
n ¼ 396 122 98 88 169 103 164
Mean 6 SE. Concentrations used: CsA, 2 mM; KPA, 50 mg/ml; DIDS, 300 mM; Ca21, 150 mM; CATR, 5 mM; alamethicin, 80 mg/ml.
*Data that are statistically different from the control.
yData that are statistically different from data for high [Ca21].
zData that are statistically different from data for CATR (P , 0.001); n, number of measurements.
FIGURE 6 Electron micrographs made using conventional ﬁxation and silver enhancement show that 6-nm particles do not enter ICM. Representative
micrographs show ICM after 10 min preincubation in the control solution under lower (A) and higher (B) resolution.
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(61). However, the real diameter is bigger due to a dextran
shell, which should add at least 1 nm to the diameter of fer-
ritin iron core (61). This in agreement with our conclusion
that the size of VDAC pore is $3 nm.
PT pore in ICM
In many cells, programmed cell death, apoptosis, is triggered
by the release of apoptogenic proteins from the MIMS, of
which cytochrome c oxidase is the major player (14). Once
released, this protein activates a cascade of events leading to
apoptotic or necrotic death (14,2). The role of the PT in these
processes remains controversial (14,2). Our experiments
with 6-nm particles, CATR, and high [Ca21] helps to clarify
the possible mechanisms of PT-related release of cytochrome
c oxidase. Cytochrome c was shown be released from MIMS
as a result of PT-related swelling followed by the OMM
rupture (12–14), through the VDAC’s tetramers (32), and/or
through the 4-nm MAC (8,9). However, the channel activity
of MAC depends on the presence of proapoptotic Bax in the
OMM. Prevention of Bax translocation from the cytoplasm
to the OMM prevents formation of MAC and apoptosis (8).
CATR induced the entrance of 6-nm particles through the
OMM, which could not be through MAC since these ex-
periments were nominally Bax-free. If CATR did not induce
mitochondrial synthesis of ceramides (that has not been
shown so far) and the opening of 10 nm pores in the OMM
(11), only a modiﬁed or reorganized VDAC and/or swelling-
induced OMM damage could be involved in the penetration
of 6-nm particles under our experimental conditions.
In our experiments, CATR signiﬁcantly changed the
diameter of the mitochondria (Table 2). Although the ICM
after CATR had much poorer structural integrity than under
control conditions, the damage was not as great as after
alamethicin treatment (Fig. 7 B) or high [Ca21] (Fig. 7 C),
and the aggregation of nanoparticles in the middle of the
FIGURE 7 Pore formation allows 6-nm particles to enter theMIMS. Repre-
sentative electron micrographs made using conventional ﬁxation and silver
enhancement show ICM after 10 min preincubation in solutions containing
5 mM CATR (A), 80 mg/ml alamethicin (B), or 150 mM Ca21 (C).
Nanoparticles were added to the ICM 10 min after pore former. (A) All bars,
0.25 mm. (B) All bars, 0.5 mm. (D) The graph shows the load of ICM by the
particles under marked conditions. Asterisks indicate data that are statisti-
cally different from the corresponding control (P , 0.01); n ¼ 65–164
(see Table 1).
FIGURE 8 Pore formation reduces the number of nanoparticles attached
to OMM. The graph shows the number of particles attached to OMM of ICM
for control conditions and after preincubation of ICM with 5 mM CATR,
80 mg/ml alamethicin (Ala), or 150 mMCa21 (see Fig. 7). Asterisks indicate
data that are statistically different from the corresponding control (P ,
0.01); n ¼ 65–164 (see Table 1).
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mitochondrion (Fig. 7 A) also suggests that they retained
functional integrity. However, taking into account the ;3
times lower original density of 6-nm particles in the experi-
mental solution and the ;3 times increase in volume, the
permeation of the ICM OMM after CATR for 6-nm particles
was ;1.5 times higher than the permeation for the 3-nm
particles under control conditions through VDAC. This
means that the number of available pores for 6 nm particles
after CATR was about twice what it was for 3-nm particles
under control conditions. If the 6 nm particles entered the
MIMS because the VDACs were reorganized into tetramers
(32), then we would expect to see a fourfold reduction in
mitochondrial density of nanoparticles as compared to the
3 nm particles. Instead we recorded ;100% increase in per-
meability. Thus, they could not enter MIMS through VDACs
reorganized into tetramers, and VDAC tetramers are unlikely
to be the pathway for cytochrome c oxidase to leave MIMS
during mitochondrial swelling.
Thus, CATR-induced increase in OMM permeation could
have resulted only from swelling-related OMM damage
(51,13). This was also conﬁrmed by the signiﬁcant reduction
in the number of 6-nm particles attached externally to the
OMM after CATR treatment (Table 1). The density of at-
tached particles even after correction for changes in ICM
diameters (Table 2) was ;2 times less than under control
conditions. Curiously, this number almost matched the 1.53
increase discussed above in the number of 6-nm particles
within ICM.
Thus, we suggest that under our experimental conditions,
PT resulted in damage to the OMM, creating breaches in the
membrane. These PT-related openings in OMM, as mea-
sured with nanoparticles, would be big enough to release
cytochrome c oxidase from MIMS and are not the result of
reorganized VDACs.
Availability of VDAC for 3-nm particles in vivo
In our previous article (3), we showed that connecting pillars
seen between IMFM and junctional SR (jSR) are not ﬁxation
artifacts but really exist in vivo. As a result, the jSR is so
close to IMFM that gaps between them are not available even
for 3-nm particles.
FIGURE 9 Distribution of GFP in rat ventricular myocytes 48 h after adenoviral transfection. GFP ﬂuorescence visualizes intracellular aqueous diffusion
pathways. Representative x-y images of intact (from two cells, A, C, and D) ventricular cells, and the cells after saponin permeabilization (B and E) show the
absence of GFP in major groups of mitochondria: perinuclear, subsarcolemmal, and intermyoﬁbrillar. (A and E) Lower panels represent images of areas marked
with dotted square on upper images but with higher magniﬁcation. (B) 1 min permeabilization. Detection gain was increased 1.35 times to compensate for the
decrease in ﬂuorescence due to leak of GFP. All other images were recorded and presented using the same recording and presenting parameters. Therefore, the
difference in ﬂuorescence represents the difference in GFP production by the cells. (E) 30 s permeabilization. Multiple GFP-ﬁlled blebs indicate gentle
permeabilization. N, nucleus; SSM, subsarcolemmal; PNM, perinuclear; and IMFM, intermyoﬁbrillar mitochondrion. [Ca21] ¼ 90 nM.
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Our current experiments with 6-nm particles indirectly
conﬁrmed the existence of such tight contacts between
mitochondria and surrounding cell structures. In the nano-
particles, only the gold core is ‘‘sticky’’ because it has
positive charges. Coating the gold particles$6 nm with PVP
prevents the aggregation of the particles, but does not
prevent their nonspeciﬁc binding to the glycocalyx of intact
ventricular cells (3). This could be explained by the existence
of unevenness in the PVP-coating of particles$6 nm, which
made the positive charged gold available to long branches of
glycoproteins. We have to suggest the same for the ICM;
however, the existence of such proteins on outer side of the
OMM has not been shown yet. The connecting pillars that
are seen very well on EM micrographs of intact ventricular
cells (see Parfenov et al. (3)) are assumed to be disrupted
during the ICM preparation. Thus, only the existence of their
remains on the OMM outer surface could reasonably explain
the attachment of 6-nm particles. Indeed, Table 1 shows
that the attachment of 6-nm particles to ICM OMM is 70
times the attachment to OMM of mitochondria in permea-
bilized cells.
Comparison of data from permeabilized ventricular cells
and ICM also shows a signiﬁcant difference in the perme-
ation of OMM (Table 1); 3-nm particles are found in 20
times greater amounts in ICM than in permeabilized ventric-
ular cells. This could result from OMM damage during
isolation of the cardiac mitochondria. However, blocking
the entrance of 3-nm nanoparticles with VDAC inhibitors
assumes that ICMOMMwas not damaged. If this is the case,
then VDAC inhibitors would have no effect on the entrance
of 3-nm nanoparticles, which is what we found. There are
only two possible explanations for seeing less 3 nm particles
in permeabilized cells: ﬁrst, diffusion of 3 nm particles in
permeabilized cells was very slow so that under our con-
ditions there was not enough time for more particles to enter;
or second, VDAC is almost unavailable, either by restricted
access or some other factor, for 3 nm particles in vivo. The
diffusion limitation for ADP in close proximity to mitochon-
dria was shown recently in saponin-permeabilized heart
bundles (62). However, our experiments with GFP conﬁrmed
that fast diffusion of molecules as big as the nanoparticles
used here was possible, when permeabilization is really
complete (Fig. 9). We used similar permeabilization for de-
livery of nanoparticles into ventricular cells. Thus, the ﬁrst
possibility does not seem reasonable. The second explana-
tion is more likely given the fact that mitochondria have
multiple structural connections with the network SR. Earlier
we have shown that these can block the entrance for 3-nm
particles to the cleft between IMFM and jSR (3). Another
explanation is that the VDAC pore entrance in vivo could be
covered by huge hexokinases II (12,63,7,1), which could be
lost during the preparation of ICM.
The hypothesis that the VDAC pore availability is re-
stricted in their real environment was conﬁrmed in our ex-
periments with GFP. Although the size and charge of GFP
should allow it to pass through the VDAC (1), we did not
ﬁnd it within the mitochondria of intact transfected ventric-
ular cells (Fig. 9) as would be expected if the VDACs were
available.
The expressed GFP was found primarily along Z-lines and
within nuclei. This is in agreement with our data described
earlier for the distribution of 3- and 6-nm particles in
permeabilized ventricular cells (3). Interestingly, permeabi-
lization of the cell with saponin released the GFP much faster
from the myoﬁlament zone than from the nucleus (Fig. 9, A
and B). Comparison of our data with data from Bustamante
et al. ((64); they used FITC-labeled dendrimers of 5.4 nm)
suggests that particles;5.5 nm can freely diffuse through car-
diac nuclear pores. Thus, contrary to zones along the Z-line,
GFP could adhere to nuclear structures, slowing down the
saponin-stimulated release.
CONCLUSIONS
The presented data allowed us to conclude that:
1. 3-nm particles enter the MIMS through VDAC.
2. The physical diameter of the VDAC pore is $3 nm but
#6 nm.
3. PT damages the OMM and opens it for particles $6 nm
in size.
4. Ca21 overload of ICM induces mitochondrial swelling
and disruption of the OMM.
5. The OMM has multiple connectors to surrounding intra-
cellular structures.
6. The VDAC pore and MIMS are unreachable in vivo for
particles #3-nm in size.
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